SMARCA4 and neoplasm: For instance, Jones et al., 2021 [28] developed the PRecur model, a gradient-boosted machine learning framework that combines clinicopathologic variables such as the tumor size and histological subtype with genomic data like TP53 and SMARCA4 mutations.